Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients : Results from the TEAMIIA study (BOOG2006-04)

MLA

Fontein, D. B. Y., et al. Specific Adverse Events Are Associated with Response to Exemestane Therapy in Postmenopausal Breast Cancer Patients : Results from the TEAMIIA Study (BOOG2006-04). 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1303690118&authtype=sso&custid=ns315887.

APA

Fontein, D. B. Y., Charehbili, A., Nortier, J. W. R., Putter, H., Kranenbarg, E. M. K., Kroep, J. R., Linn, S. C., & van de Velde, C. J. H. (2017). Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients : Results from the TEAMIIA study (BOOG2006-04).

Chicago

Fontein, D. B Y, A. Charehbili, J. W R Nortier, H. Putter, E. Meershoek Klein Kranenbarg, J. R. Kroep, S. C. Linn, and C. J H van de Velde. 2017. “Specific Adverse Events Are Associated with Response to Exemestane Therapy in Postmenopausal Breast Cancer Patients : Results from the TEAMIIA Study (BOOG2006-04).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1303690118&authtype=sso&custid=ns315887.